---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-035736"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2022-12-16T23:59:59+00:00"
generated_at: "2026-06-21T03:26:19.379524+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# AgeX borrows additional $1M from Juvenescence, total $12.66M; issues warrants for 847K shares at $0.59

## Summary
- Borrowed additional $1,000,000 under Secured Convertible Note with Juvenescence. Total outstanding balance now $12,660,000.
- Remaining $500,000 line of credit may be drawn subject to Juvenescence's discretion through first anniversary date.
- In connection with draw, will issue warrants to purchase 847,457 shares of common stock at $0.59 per share.
- Secured Note matures on February 14, 2024; origination fee 4% per draw plus additional 4% after 12 months.

## SEC filing metadata
- accession: 0001493152-22-035736
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2022-12-16T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315222035736/0001493152-22-035736-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315222035736/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-035736
- JSON: https://secwatch.observer/filing/0001493152-22-035736.json
- Plain text: https://secwatch.observer/filing/0001493152-22-035736.txt

## Key facts
- Debt Financings
  Serina Therapeutics, Inc. incurred convertible notes of $1,000,000 with Juvenescence Limited at 4% of the amount each draw of loan funds, which will accrue as each draw is fund maturing February 14, 2024.
  - Instrument: convertible notes
  - Principal: $1,000,000
  - Counterparty: Juvenescence Limited
  - Rate: 4% of the amount each draw of loan funds, which will accrue as each draw is fund
  - Maturity: February 14, 2024
  - Event: incurrence
  source text: On December 14, 2022, AgeX borrowed an additional $1,000,000 under the Secured Convertible Promissory Note (the “Secured Note”) dated as of February 14, 2022 with Juvenescence Limited (“Juvenescence”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315222035736/0001493152-22-035736-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.